107351-59-7

Basic information

• Product Name: METHYL 4-(ACETYLAMINO)-2-(BENZYLOXY)BENZOATE
• Synonyms: METHYL 4-(ACETYLAMINO)-2-(BENZYLOXY)BENZOATE;methyl 2-(benzyloxy)-4-acetamidobenzoate
• CAS NO: 107351-59-7
• Molecular Formula: C₁₇H₁₇NO₄
• Molecular Weight: 299.32118
• Mol File: 107351-59-7.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 4-(ACETYLAMINO)-2-(BENZYLOXY)BENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-(ACETYLAMINO)-2-(BENZYLOXY)BENZOATE(107351-59-7)
• EPA Substance Registry System: METHYL 4-(ACETYLAMINO)-2-(BENZYLOXY)BENZOATE(107351-59-7)

Safety Data

• Hazardous Substances Data: 107351-59-7(Hazardous Substances Data)

Upstream product

• 4093-28-1 methyl 4-acetamido-2-hydroxybenzoate 
• 100-39-0 benzyl bromide 
• 65-49-6 4-Aminosalicylic acid 
• 4136-97-4 methyl 4-aminosalicylate 
• 100-44-7 benzyl chloride 
• 27727-70-4 methyl 4-amino-2-(benzyloxy)benzoate 
• 75-36-5 acetyl chloride 

Downstream Products

• 107351-60-0 N-(3-(benzyloxy)-4-(hydroxymethyl)phenyl)acetamide 
• 89882-69-9 N-(3-(benzyloxy)-4-formylphenyl)acetamide 
• 107351-64-4 4-benzyloxy-6-aminoindole-2-carboxylic acid methyl ester 
• 89882-70-2 4-benzyloxy-6-acetylaminoindole-2-carboxylic acid methyl ester 
• 4093-28-1 methyl 4-acetamido-2-hydroxybenzoate 
• 107351-63-3 C₁₉H₁₈N₄O₄ 
• 55543-74-3 4-acetamido-2-(benzyloxy)benzoic acid 

Relevant articles and documents

Micromolecular non-nucleoside compound as immunomodulator

The invention discloses a structure, a preparation method and application of a micromolecular non-nucleoside targeted CD73 immunomodulator. The structure of the compound is shown as a general formula (I), and R1, R2, R3, R4, R5, X, Y and W groups are defined as in the claims. The compound acts on CD73 protein, blocks the interaction between the CD73 protein and a substrate of the CD73 protein, and can be used for preparing medicines and/or compositions for treating and/or diagnosing cancers, infectious diseases, autoimmune diseases and neurodegenerative diseases.

Substituted benzene and heterocyclic compound and its preparation method and application

The invention provides substituted benzoheterocyclic compounds and a preparation method thereof. The compounds have structures shown by formulas I and II. The invention also provides the effects of the compounds shown by formulas I and II in resisting virus, tumor and the like. The invention further provides a medicine composition taking the compounds shown by the formulas I and II as active ingredients, and the anti-virus or anti-tumor effect of the medicine composition. The invention lays a foundation for the future in-depth study and development of the anti-virus or anti-tumor medicine of the compounds.

SYNTHESIS OF THE BACTERIAL COENZYME METHOXATIN

A short total synthesis of the bacterial coenzyme methoxatin (1) (4,5-dihydro-4,5-dioxo-1H-pyrroloquinoline-2,7,9-tricarboxylic acid) is described.The route involves the two step conversion of 4-acetamido-2-benzyloxybenzaldehyde (5b) into methyl 6-acetamido-4-benzyloxyindole-2-carboxylate (7b) (74percent), followed by regioselective annulation of the third ring (55percent), and debenzylation and oxidation with benzoyl t-butyl nitroxide to give the tricyclic quinone triester (13) (methoxatin triester) (83percent).